Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study

NCT07739511 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HER2 + Breast Cancer

Interventions

COMBINATION_PRODUCT: Paclitaxel oral solution plus Trastuzumab and Pertuzumab

Sponsor

Liu Shu